Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 176

1.

Gene expression profiling of isogenic cells with different TP53 gene dosage reveals numerous genes that are affected by TP53 dosage and identifies CSPG2 as a direct target of p53.

Yoon H, Liyanarachchi S, Wright FA, Davuluri R, Lockman JC, de la Chapelle A, Pellegata NS.

Proc Natl Acad Sci U S A. 2002 Nov 26;99(24):15632-7.

3.

Semaphorin-plexin signalling genes associated with human breast tumourigenesis.

Gabrovska PN, Smith RA, Tiang T, Weinstein SR, Haupt LM, Griffiths LR.

Gene. 2011 Dec 10;489(2):63-9. doi: 10.1016/j.gene.2011.08.024.

PMID:
21925246
4.

Expression of androgen receptor is negatively regulated by p53.

Alimirah F, Panchanathan R, Chen J, Zhang X, Ho SM, Choubey D.

Neoplasia. 2007 Dec;9(12):1152-9.

5.

The different radiation response and radiation-induced bystander effects in colorectal carcinoma cells differing in p53 status.

Widel M, Lalik A, Krzywon A, Poleszczuk J, Fujarewicz K, Rzeszowska-Wolny J.

Mutat Res. 2015 Aug;778:61-70. doi: 10.1016/j.mrfmmm.2015.06.003.

PMID:
26099456
6.

Global genechip profiling to identify genes responsive to p53-induced growth arrest and apoptosis in human lung carcinoma cells.

Robinson M, Jiang P, Cui J, Li J, Wang Y, Swaroop M, Madore S, Lawrence TS, Sun Y.

Cancer Biol Ther. 2003 Jul-Aug;2(4):406-15.

PMID:
14508115
7.

Heat shock protein-90-alpha, a prolactin-STAT5 target gene identified in breast cancer cells, is involved in apoptosis regulation.

Perotti C, Liu R, Parusel CT, Böcher N, Schultz J, Bork P, Pfitzner E, Groner B, Shemanko CS.

Breast Cancer Res. 2008;10(6):R94. doi: 10.1186/bcr2193.

8.

Tissue-wide expression profiling using cDNA subtraction and microarrays to identify tumor-specific genes.

Amatschek S, Koenig U, Auer H, Steinlein P, Pacher M, Gruenfelder A, Dekan G, Vogl S, Kubista E, Heider KH, Stratowa C, Schreiber M, Sommergruber W.

Cancer Res. 2004 Feb 1;64(3):844-56.

9.

Microarray analysis detects novel Pax3 downstream target genes.

Mayanil CS, George D, Freilich L, Miljan EJ, Mania-Farnell B, McLone DG, Bremer EG.

J Biol Chem. 2001 Dec 28;276(52):49299-309.

10.

Identification of 5-fluorouracil-inducible target genes using cDNA microarray profiling.

Maxwell PJ, Longley DB, Latif T, Boyer J, Allen W, Lynch M, McDermott U, Harkin DP, Allegra CJ, Johnston PG.

Cancer Res. 2003 Aug 1;63(15):4602-6.

11.

Sensitization and caffeine potentiation of cisplatin cytotoxicity resulting from introduction of wild-type p53 gene in human osteosarcoma.

Tsuchiya H, Mori Y, Ueda Y, Okada G, Tomita K.

Anticancer Res. 2000 Jan-Feb;20(1A):235-42.

PMID:
10769661
12.

BRCA1 activation of the GADD45 promoter.

Jin S, Zhao H, Fan F, Blanck P, Fan W, Colchagie AB, Fornace AJ Jr, Zhan Q.

Oncogene. 2000 Aug 17;19(35):4050-7.

PMID:
10962562
13.

Profiling of differential expression of messenger RNA in normal, benign, and metastatic prostate cell lines.

Chakrabarti R, Robles LD, Gibson J, Muroski M.

Cancer Genet Cytogenet. 2002 Dec;139(2):115-25.

PMID:
12550771
14.

C-erbB-2/ HER-2 upregulates fascin, an actin-bundling protein associated with cell motility, in human breast cancer cell lines.

Grothey A, Hashizume R, Ji H, Tubb BE, Patrick CW Jr, Yu D, Mooney EE, McCrea PD.

Oncogene. 2000 Oct 5;19(42):4864-75.

15.

Estrogen receptor alpha inhibits p53-mediated transcriptional repression: implications for the regulation of apoptosis.

Sayeed A, Konduri SD, Liu W, Bansal S, Li F, Das GM.

Cancer Res. 2007 Aug 15;67(16):7746-55.

16.

Transcriptional repression of the anti-apoptotic survivin gene by wild type p53.

Hoffman WH, Biade S, Zilfou JT, Chen J, Murphy M.

J Biol Chem. 2002 Feb 1;277(5):3247-57.

17.

Loss of TP53-DNA interaction induced by p.C135R in lung cancer.

Aranda M, Gonzalez-Nilo F, Riadi G, Díaz V, Perez J, Martel G, Hainaut P, Mimbacas A.

Oncol Rep. 2007 Nov;18(5):1213-7.

PMID:
17914575
18.

The proapoptotic gene SIVA is a direct transcriptional target for the tumor suppressors p53 and E2F1.

Fortin A, MacLaurin JG, Arbour N, Cregan SP, Kushwaha N, Callaghan SM, Park DS, Albert PR, Slack RS.

J Biol Chem. 2004 Jul 2;279(27):28706-14.

Items per page

Supplemental Content

Support Center